PTGS2 and breast carcinoma: At higher anti-inflammatory doses (>325 mg daily), aspirin additionally inhibits cyclooxygenase-2 (COX-2), an enzyme commonly overexpressed in aggressive breast cancers and associated with poorer prognosis [5].